| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On January 7, 2008
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| 1994D-0025
|
| Guidelines on the Voluntary Labeling Milk & Milk Products from Cows That Have Not Been Treated with rbSt or rbGH
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2005P-0433
|
| Adoption of Harmonization Policy by the U.S. Codex Delegation and US Policy in harmony with DSHEA and 19 U.S.C. 3512
|
|
|
|
|
| 2006N-0466
|
| Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2007D-0364
|
| Impact-Resistant Lenses: Questions and Answers Guidance
|
|
|
|
|
| 2007D-0367
|
| Guidance for Industry on Antibacterial Drug Products: Use of Noninferiority Studies to Support Approval
|
|
|
|
|
| 2007D-0419
|
| Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment; Draft Guidance
|
|
|
|
|
| 2007H-0433
|
| Civil Money Penalty; Advanced Bionics Corporation
|
|
|
|
|
| 2007N-0280
|
| Amendment to the CGMP Regulations for Finished Pharmaceuticals
|
|
|
|
|
| 2007N-0485
|
| Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Food and Drug Administration Approval to Market a New Drug
|
|
|
|
|
|
|
|
|
| 2007N-0487
|
| Meeting being planned to obtain public input for ensuring the safety of pet food
|
|
|
|
|
| 2007N-0489
|
| Request for Comments on the Science and Technology Report; Establishment of Docket; Request for Comments
|
|
|
|
|
| 2007P-0331
|
| Ban Use of Mercury In Medicine,UNLESS Proven Toxicologically Safe to the CGMP Standard Sufficiently Nontoxic
|
|
|
|
|
| 2008P-0006
|
| To determine whether Didrex 25 mg (benzphetmine hydrochloride) Tablets (NDA 12-427) by Pharmacia and Upjohn Company, has been voluntarily withdrawn or withheld from sale for safety or efficacy reasons
|
|
|
|
|
|
| 2008P-0010
|
| Over-the-Counter (OTC) Pertaining to Cough/Cold Drug Products Containg Tannates
|
|
|
|
|
| 2008V-0008
|
| Laser Light Show
|
|
| |
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| C 726
|
| Duke Surgery, Duke University Medical Center
|
| Vol #:
|
| 182
|
|
| |
|
| 1994D-0025
|
| Guidelines on the Voluntary Labeling Milk & Milk Products from Cows That Have Not Been Treated with rbSt or rbGH
|
|
|
|
|
| ANS 12
|
| FDA/Executive Secretariat to Robert & Mary Fuhs
|
| Vol #:
|
| 71
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET 21271
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21272
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21273
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21274
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21275
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21276
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21277
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21278
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21279
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21280
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
| | | | | | | | |
|
| |
|
| LET 21281
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21282
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21283
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21284
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21285
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21286
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21287
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21288
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21289
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21290
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21291
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21292
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21293
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21294
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| LET 21295
|
| Isaac Marcum
|
| Vol #:
|
| 183
|
|
|
|
|
| 2005P-0433
|
| Adoption of Harmonization Policy by the U.S. Codex Delegation and US Policy in harmony with DSHEA and 19 U.S.C. 3512
|
|
|
|
|
| C 9
|
| Natural Solutions Foundation
|
| Vol #:
|
| 2
|
|
|
|
|
| C 10
|
| Natural Solutions Foundation
|
| Vol #:
|
| 3
|
|
|
|
|
| C 11
|
| Natural Solutions Foundation
|
| Vol #:
|
| 4
|
|
|
|
|
| C 12
|
| Natural Solutions Foundation
|
| Vol #:
|
| 5
|
|
|
|
|
| C 13
|
| Natural Solutions Foundation
|
| Vol #:
|
| 6
|
|
|
|
|
| 2006N-0466
|
| Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile
|
|
|
|
|
| EREG 1
|
| J. Breen
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| C 525
|
| D. Baker
|
| Vol #:
|
| 14
|
|
|
|
|
| 2007D-0364
|
| Impact-Resistant Lenses: Questions and Answers Guidance
|
|
|
|
|
| EC 16
|
| Spectacles
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 17
|
| Professional Optician of Florida
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 18
|
| Mr. Alan Rubin
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 19
|
| Durham Optical
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 20
|
| Professional Opticians of Florida
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 21
|
| Mr. Gary Harris
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0367
|
| Guidance for Industry on Antibacterial Drug Products: Use of Noninferiority Studies to Support Approval
|
|
|
|
|
| NEC 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| 2007D-0419
|
| Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment; Draft Guidance
|
|
|
|
|
| C 1
|
| Sanofi Aventis
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007H-0433
|
| Civil Money Penalty; Advanced Bionics Corporation
|
|
|
|
|
| CS 2
|
| FDA/DDM
|
| Vol #:
|
| 1
|
|
|
|
|
| OR 2
|
| FDA/Administrative Law Judge
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0280
|
| Amendment to the CGMP Regulations for Finished Pharmaceuticals
|
|
|
|
|
| EREG 1
|
| M. Jornitz
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0485
|
| Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Food and Drug Administration Approval to Market a New Drug
|
|
|
|
|
|
| |
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0487
|
| Meeting being planned to obtain public input for ensuring the safety of pet food
|
|
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0489
|
| Request for Comments on the Science and Technology Report; Establishment of Docket; Request for Comments
|
|
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0331
|
| Ban Use of Mercury In Medicine,UNLESS Proven Toxicologically Safe to the CGMP Standard Sufficiently Nontoxic
|
|
|
|
|
| EC 12
|
| Fresno City College Student
|
| Vol #:
|
| 2
|
|
|
|
|
| 2008P-0006
|
| To determine whether Didrex 25 mg (benzphetmine hydrochloride) Tablets (NDA 12-427) by Pharmacia and Upjohn Company, has been voluntarily withdrawn or withheld from sale for safety or efficacy reasons
|
|
|
|
|
|
| |
|
|
|
| ACK 1
|
| FDA/ DDM to Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2008P-0010
|
| Over-the-Counter (OTC) Pertaining to Cough/Cold Drug Products Containg Tannates
|
|
|
|
|
| ACK 1
|
| FDA/ DDM to Tannates Working Group
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Tannates Working Group
|
| Vol #:
|
| 1
|
|
|
|
|
| 2008V-0008
|
| Laser Light Show
|
|
|
|
|
| ACK 1
|
| FDA/ DDM to See Touring Productions, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| VAR 1
|
| See Touring Productions, Inc.
|
| Vol #:
|
| 1
|
|
